Tissue Repair Ltd (TRP.AX)
AUD 0.27
(0.0%)
AUD 0.27
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 19.38 Million AUD | -13.36% |
| 2023 | 22.37 Million AUD | -13.59% |
| 2022 | 25.89 Million AUD | -6.2% |
| 2021 | 27.6 Million AUD | 1977.4% |
| 2020 | 1.32 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 19.38 Million AUD | -5.83% |
| 2024 Q2 | 20.58 Million AUD | 0.0% |
| 2024 FY | 19.38 Million AUD | -13.36% |
| 2024 Q1 | 20.58 Million AUD | -20.5% |
| 2024 Q4 | 19.38 Million AUD | 0.0% |
| 2023 Q1 | 23.2 Million AUD | -10.38% |
| 2023 FY | 22.37 Million AUD | -13.59% |
| 2023 Q3 | 22.37 Million AUD | -3.58% |
| 2023 Q4 | 25.89 Million AUD | 15.72% |
| 2023 Q2 | 23.2 Million AUD | 0.0% |
| 2022 Q1 | 27.24 Million AUD | 235.37% |
| 2022 FY | 25.89 Million AUD | -6.2% |
| 2022 Q4 | 25.89 Million AUD | 0.0% |
| 2022 Q3 | 25.89 Million AUD | -4.95% |
| 2022 Q2 | 27.24 Million AUD | 0.0% |
| 2021 Q3 | 8.12 Million AUD | 0.0% |
| 2021 FY | 27.6 Million AUD | 1977.4% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 Q4 | 8.12 Million AUD | 0.0% |
| 2020 FY | 1.32 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 24.117% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -1060.065% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -274.069% |
| Biome Australia Limited | 8.27 Million AUD | -134.264% |
| Patrys Limited | 4.16 Million AUD | -365.919% |
| Orthocell Limited | 26.61 Million AUD | 27.149% |
| Imugene Limited | 151.39 Million AUD | 87.193% |
| Noxopharm Limited | 6.78 Million AUD | -185.824% |
| PYC Therapeutics Limited | 91.23 Million AUD | 78.749% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -26.952% |
| Prescient Therapeutics Limited | 20.39 Million AUD | 4.92% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -78.293% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -131.151% |
| CSL Limited | 56.93 Billion AUD | 99.966% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -45.954% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -513.674% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 91.611% |
| Starpharma Holdings Limited | 36.81 Million AUD | 47.331% |
| Nanollose Limited | 241.95 Thousand AUD | -7913.845% |
| Memphasys Limited | 12.43 Million AUD | -55.988% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -216.821% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -256.697% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -30.613% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 82.759% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -656.085% |
| Race Oncology Limited | 20.22 Million AUD | 4.148% |
| Nyrada Inc. | 5.9 Million AUD | -228.233% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 95.132% |
| Dimerix Limited | 32.07 Million AUD | 39.556% |
| PharmAust Limited | 11.12 Million AUD | -74.291% |
| Immutep Limited | 147.44 Million AUD | 86.85% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 87.461% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -0.863% |
| BTC Health Limited | 5.14 Million AUD | -276.584% |
| Acrux Limited | 8.96 Million AUD | -116.329% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 92.181% |
| Biotron Limited | 493.47 Thousand AUD | -3829.184% |
| AdAlta Limited | 5.57 Million AUD | -247.92% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 73.084% |
| Hexima Limited | 2.26 Million AUD | -754.541% |
| AnteoTech Limited | 9.38 Million AUD | -106.686% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 29.21% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -204.407% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -164.91% |
| Actinogen Medical Limited | 21.31 Million AUD | 9.02% |
| Immuron Limited | 15.54 Million AUD | -24.692% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -18.391% |